Australian Society for Antimicrobials
PO Box 8266 Angelo St, South Perth, Western Australia 6151
Fax: 61 8 9450 8553, Email: info@asainc.net.au, Twitter: @AusAntibiotics
Login:
Password:
 

Welcome to the web site of the Australian Society for Antimicrobials.

Since becoming an Incorporated Society in March 1999, ASA membership now covers a diverse background of professions interested in the study of antimicrobials including clinical microbiologists and infectious diseases physicians, respiratory and ICU physicians, medical and non-medical microbiologists and scientists, pharmacists, veterinarians, undergraduate and postgraduate students, and industry representatives from pharmaceutical and diagnostic/research biomedical companies.
On this site you can access the Society's Objectives, Constitution and the Committee Members.
The Society's Membership Subscription Form and details of the Annual Scientific Meeting can be downloaded.
Members of the Society can download current and previous newsletters, as well as abstracts from previous annual scientific meetings, in the Members Area.
Although ASA's membership is primarily based in Australia and New Zealand, it now extends to Asia, North America, Europe and the United Kingdom.
ANTIMICROBIALS 2017 and STAPHPATH 2017
23rd - 25th February 25th - 26th February
at the Adelaide Convention Centre - Click here for details and Programs

30 November - 3 December 2016

Melbourne Convention Exhibition Centre



Latest BREAK POINT Newsletter

  - past newsletters available on the Public Newsletters page

Current Newsletter (members only):

(You must be logged in to view this newsletter.)

  • ASA Subscription
  • In the News
  • Zoonotic Transmission of the Methicillin-resistant Staphylococcus aureus ST612-IV Equine Strain
  • Vancomycin Resistant E. faecium: Not just a Breakpoint Issue
  • Meeting Calendar



Latest ASA News

  - more on the ASA News page

23
Jun
2016
Advances in Microbial Genomics for Public Health and Clinical Microbiology Symposium
Given the dynamic and dispersed nature of pathogenic microbes and the relentless rise of superbugs that are resistant to almost all classes of antibiotics, preventing and controlling the spread of infectious diseases in humans, in animals, and in our food and water will require timely, effective and high-resolution responses. Genomics is revolutionizing all aspects of microbiology and in forward thinking countries around the world is transforming approaches to controlling the spread of public health and clinical microbiological pathogens. 
 
Doherty Applied Microbial Genomics will be hosting a one-day symposium at the Peter Doherty Institute for Infection & Immunity, entitled “Advances in Microbial Genomics for Public Health and Clinical Microbiology” that will critically examine the impact of microbial genomics on public health and clinical microbiology practice overseas and in Australia, and show how this cutting edge technology is helping protect the public from the threat of infectious diseases.
 
Confirmed speakers include international experts Prof Jennifer Gardy from the British Columbia Centre for Disease Control and Dr Phil Ashton from Public Health England, as well as national experts in the fields of applied microbial genomics, epidemiology and antimicrobial resistance that includes Prof Eddie Holmes from the University of Sydney, Prof Darren Trott from the University of Adelaide, Prof Jodie McVernon from the University of Melbourne and A/ Prof Torsten Seemann the Lead Bioinformatician at Doherty Applied Microbial Genomics.
 
The target audience are researchers, clinicians, epidemiologists, public health professionals and veterinarians.
 
The preliminary program is available to download here
 
WHEN
Tuesday, 15 November 2016 from 8:00 AM to 6:30 PM (AEDT) - Add to Calendar
WHERE
The Peter Doherty Institute for Infection and Immunity - 792 Elizabeth Street, Melbourne, VIC 3000 - View Map
 
 
12
Jun
2016
Preliminary Announcement: Antimicrobials 2017 and StaphPath 2017
On behalf of the Australian Society for Antimicrobials I would like to invite you to the Society’s 18th Annual Scientific Meeting “Antimicrobials 2017” and to the inaugural “StaphPath 2017” to be held at the Adelaide Convention Centre and the Intercontinental Hotel, Adelaide, on Thursday 23rd – Sunday 26th February 2017.
 
“Antimicrobials 2017” and “StaphPath 2017” will share joint symposia on Saturday 25th February 2017. 
 
Antimicrobials 2017 (Thursday 23rd – Saturday 25th February 2017)
 
I am pleased to announce William Hope, The University of Liverpool, UK; Stefan Schwarz, Federal Research Institute for Animal Health, Germany; and Geraint Rogers, Flinders University, South Australia will be participating at the meeting.  William will be presenting the plenary “PK/PD in Everyday Antimicrobial Treatment”, and Stefan will be presenting “One Health Aspects of Antimicrobial Resistance in Gram Negative Bacteria and Enterococci".  Geraint’s plenary will be “Antimicrobial Resistance and the Human Genome”.
 
The 2017 Howard Florey Oration will be delivered by Tim Walsh, Cardiff University, Wales.  
 
The program’s symposia cover many different aspects on antimicrobials and symposium sessions include “Mycology”, “The Cutting Edge: Resistance Detection and Management, “New Frontiers: The Human Resistome and Metagenomics”, “Enterococci”, “Staphylococcal Topics”, “Global MRSA Epidemiology” and “Antibiotic Resistance and Staphylococcal Mobile Genomic Elements”.   In addition, we have two pharmacy symposia on Saturday afternoon titled “System wide Initiatives” and "From Theory to Bedside”.  Six proffered papers and two poster sessions are also planned for the meeting.
 
To celebrate the 100th anniversary of the birth of Howard Florey the “Antimicrobials 2017” registration will include a formal dinner at the Adelaide Town Hall.
 
StaphPath 2017 (Saturday 25th – Sunday 26th February 2017)
 
 
In addition to the “Staphylococcal Topics”, “Global MRSA Epidemiology” and “Antibiotic Resistance and Staphylococcal Mobile Genomic Elements” symposia StaphPath 2017 will have four plenary sessions including “Staphylococcal Virulence: What does WGS tell us” (Ruth Massey, University of Bath, UK), “S. aureus and the Ecology of the Nasal Microbiome (Robert Skov, Statens Serum Institute, Denmark), “What’s new in Staphylococcal Pathogenesis” (Jodi Lindsay, St Georges’ University of London, UK), and “The Emergence of cfr in Human and Animal Staphylococci” (Stefan Schwarz).  Three additional symposia are also scheduled including “ST93 and Beyond”, “Multi-resistant Staphylococci in the Australian Veterinary Setting” and “Novel Anti-staphylococcal Approaches” A poster session is also planned for the meeting.   
 
A discounted registration will be provided for delegates attending both meetings
 
To promote discussion and interaction between delegates and the invited speakers the meetings’ registration will include lunches, morning and afternoon teas.
 
The meetings website which will include registration and abstract submission will be available in July.  
 
I am confident that you will find both meetings’ programs both scientifically stimulating and informative and we look forward to meeting you in Adelaide.
 
Ben Howden
President ASA
 
7
May
2016
17th International Symposium on Staphylococi and Staphylococcal Infections
Dear Colleagues,


We would like to invite you to the 17th International Symposium on Staphylococci and Staphylococcal Infections, to be held in Seoul, South Korea, from August 30 to September 2, 2016

The ISSSI 2016 SEOUL will cover a number of interdisciplinary subjects regarding staphylococci and staphylococcal infections. Sessions will be presented by the world's leading experts in each of the research fields. Oral and poster sessions will be an integral part of the program as well, and all delegates are invited to submit abstracts. We will also offer a lot of travel grants and a range of socializing programs to build solid friendship among the participants.


Sincerely,

ISSSI 2016 SEOUL Organizing Committee

E-mail: office@isssi2016.org 
Official Website: http://www.isssi2016.org
 
7
May
2016
Communicable Diseases Intelligence Volume 40 Supplement April 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Communicable Diseases Intelligence Volume 40 Supplement is now available

Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2008–2011

 
7
May
2016
Communicable Diseases Intelligence Volume 40 Number 1 March 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Communicable Diseases Intelligence Volume 40 Number 1 March 2016

Contents

This issue is available as a full PDF (9.2 MB) or by individual articles below.

Original article

Clinical diagnosis and chemical confirmation of ciguatera fish poisoning in New South Wales, Australia
Hazel Farrell, Anthony Zammit, D Tim Harwood, Paul McNabb, Craig Shadbolt, Jennifer Manning, John A Turahui, Debra J van den Berg, Lisa Szabo 
Full text [HTML] | Full text [PDF 359 KB]

Short report

Infectious and congenital syphilis notifications associated with an ongoing outbreak in northern Australia
Amy Bright, Australian Government Department of Health and Johanna Dups, Western Australian Department of Health, on behalf of the Multijurisdictional Syphilis Outbreak Group
Full text [HTML] | Full text [PDF 320 KB]

Surveillance summaries

Surveillance systems reported in Communicable Diseases Intelligence, 2016
Full text [HTML] | Full text [PDF 2096 KB]

Annual reports

Arboviral diseases and malaria in Australia, 2012–13: Annual report of the National Arbovirus and Malaria Advisory Committee
Katrina E Knope, Nina Kurucz, Stephen L Doggett, Mike Muller, Cheryl A Johansen, Rebecca Feldman, Michaela Hobby, Sonya Bennett, Angus Sly, Stacey Lynch, Bart J Currie, Jay Nicholson, and the National Arbovirus and Malaria Advisory Committee
Full text [HTML] | Full text [PDF 1.4 MB]
Australia’s notifiable disease status, 2014: Annual report of the National Notifiable Diseases Surveillance System
NNDSS Annual Report Working Group 
Full text [HTML] | Full text [PDF 5.4 MB]
Immunisation coverage annual report, 2013
Brynley P Hull, Aditi Dey, Frank H Beard, Robert I Menzies, Julia M Brotherton, Peter B McIntyre 
Full text [HTML] | Full text [PDF 1.7 MB]

Quarterly reports

National Notifiable Diseases Surveillance System, 1 October to 31 December 2015
Full text [HTML] | Full text [PDF 479 KB]
Australian childhood immunisation coverage, 1 July to 30 June cohort, assessed as at 30 September 2015 
Alexandra Hendry for the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases
Full text [HTML] | Full text [PDF 230 KB]
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015
Monica M Lahra, Rodney P Enriquez, The Prince of Wales Hospital, Randwick, for The National Neisseria Network 
Full text [HTML] | Full text [PDF 253 MB]
Australian Sentinel Practices Research Network, 1 October to 31 December 2015
Monique B-N Chilver, Daniel Blakeley, Nigel P Stocks for the Australian Sentinel Practices Research Network 
Full text [HTML] | Full text [PDF 287 KB]
Invasive pneumococcal disease surveillance Australia, 1 October to 31 December 2015 
Rachel de Kluyver, Cindy Toms and the Enhanced Invasive Pneumococcal Disease Surveillance Working Group, for the Communicable Diseases Network Australia 
Full text [HTML] | Full text [PDF 3857 KB]

Administration

Communicable Diseases Intelligence instructions for authors
Full text [HTML] | Full text [PDF 193 KB]

Editor: Margaret Curran
Deputy Editor: Katrina Knope 
Associate Editors: Timothy Sloan-Gardner 
Editorial and Production Staff: Alison Milton
ISSN 1445-4866 Online

Disclaimer

Opinions expressed in Communicable Diseases Intelligence are those of the authors and not necessarily those of the Australian Government Department of Health or the Communicable Diseases Network Australia. Data may be subject to revision.
 
21
Mar
2016
2016 ASA Foundation Members
The Australian Society for Antimicrobials wishes to acknowledge the following companies for becoming Foundation (Sustaining) Members of the Society
 
10
Jan
2016
Antimicrobials 2016: ASA Travel Awards
On behalf of the ASA Committee I would like to congratulate the following ASA members for being awarded an ASA travel grant to attend Antimicrobials 2016:
 
Resolving the enigma of methicillin-resistance transfer in Staphylococcus aureus
J. Ramsay, Curtin University 

Zoonotic transmission of the methicillin-resistant Staphylococcus aureus ST612-IV equine strain
E. Raby, Fiona Stanley Hospital

The vancomycin LECOFF and vanB subtypes of E. faecium isolated in Australia
T. Lee, Murdoch University
 
Each awarded has been provided with a complementary ASA registration, return economy airfares and a three day per diem
 
7
Jun
2015
Australian National Antimicrobial Resistance Strategy
The Australian National Antimicrobial Resistance Strategy has been released by the Minister for Health and Sport and the Minister for Agriculture. A copy of the strategy is available at the following links:
 
 
The Australian Society for Antimicrobials is a member of the Australian Strategic and Technical Advisory Group on Antimicrobial Resistance (ASTAG) and has been heavily engaged in the development of this national strategy.